---

$2.23

+0.0550 ( +2.54% ) 37.1K

Vyome, based in Cambridge MA, is building the world?s premier platform spanning the US-India innovation corridor. Vyome?s immediate focus is leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. By applying groundbreaking science and its unique positioning across the US-India innovation corridor, Vyome seeks to deliver lasting value to shareholders in a cost-efficient manner while upholding global standards of quality and safety.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
No records found.